Cargando…

Impact of Cluster B Personality Disorders in Drugs Therapeutic Community Treatment Outcomes: A Study Based on Real World Data

Background: The impact of dual pathology on treatment outcomes is unclear, with the literature reporting both favorable and unfavorable evidence. The main aim of this study was to determine how dual pathology affects treatment outcomes using real world data obtained from inpatients that began treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Dacosta-Sánchez, Daniel, Díaz-Batanero, Carmen, Fernandez-Calderon, Fermin, Lozano, Óscar M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230360/
https://www.ncbi.nlm.nih.gov/pubmed/34200750
http://dx.doi.org/10.3390/jcm10122572
_version_ 1783713190587138048
author Dacosta-Sánchez, Daniel
Díaz-Batanero, Carmen
Fernandez-Calderon, Fermin
Lozano, Óscar M.
author_facet Dacosta-Sánchez, Daniel
Díaz-Batanero, Carmen
Fernandez-Calderon, Fermin
Lozano, Óscar M.
author_sort Dacosta-Sánchez, Daniel
collection PubMed
description Background: The impact of dual pathology on treatment outcomes is unclear, with the literature reporting both favorable and unfavorable evidence. The main aim of this study was to determine how dual pathology affects treatment outcomes using real world data obtained from inpatients that began treatment in therapeutic communities. Method: The data of 2458 inpatients were used. Clinical information was obtained from electronic medical records. Reliability of diagnosis was checked and revealed a mean kappa value of 0.88. Results: Of the sample, 41.8% were discharged after achieving the therapeutic objectives. Patients diagnosed with Cluster B personality disorders were found to have a higher risk of dropping out of treatment (HR = 1.320; z = 2.61; p = 0.009). Conclusions: Personality traits exhibited by Cluster B patients can interfere with treatment in therapeutic communities. There is a need to develop specific interventions for these inpatient groups, which could be implemented in therapeutic communities.
format Online
Article
Text
id pubmed-8230360
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-82303602021-06-26 Impact of Cluster B Personality Disorders in Drugs Therapeutic Community Treatment Outcomes: A Study Based on Real World Data Dacosta-Sánchez, Daniel Díaz-Batanero, Carmen Fernandez-Calderon, Fermin Lozano, Óscar M. J Clin Med Article Background: The impact of dual pathology on treatment outcomes is unclear, with the literature reporting both favorable and unfavorable evidence. The main aim of this study was to determine how dual pathology affects treatment outcomes using real world data obtained from inpatients that began treatment in therapeutic communities. Method: The data of 2458 inpatients were used. Clinical information was obtained from electronic medical records. Reliability of diagnosis was checked and revealed a mean kappa value of 0.88. Results: Of the sample, 41.8% were discharged after achieving the therapeutic objectives. Patients diagnosed with Cluster B personality disorders were found to have a higher risk of dropping out of treatment (HR = 1.320; z = 2.61; p = 0.009). Conclusions: Personality traits exhibited by Cluster B patients can interfere with treatment in therapeutic communities. There is a need to develop specific interventions for these inpatient groups, which could be implemented in therapeutic communities. MDPI 2021-06-10 /pmc/articles/PMC8230360/ /pubmed/34200750 http://dx.doi.org/10.3390/jcm10122572 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Dacosta-Sánchez, Daniel
Díaz-Batanero, Carmen
Fernandez-Calderon, Fermin
Lozano, Óscar M.
Impact of Cluster B Personality Disorders in Drugs Therapeutic Community Treatment Outcomes: A Study Based on Real World Data
title Impact of Cluster B Personality Disorders in Drugs Therapeutic Community Treatment Outcomes: A Study Based on Real World Data
title_full Impact of Cluster B Personality Disorders in Drugs Therapeutic Community Treatment Outcomes: A Study Based on Real World Data
title_fullStr Impact of Cluster B Personality Disorders in Drugs Therapeutic Community Treatment Outcomes: A Study Based on Real World Data
title_full_unstemmed Impact of Cluster B Personality Disorders in Drugs Therapeutic Community Treatment Outcomes: A Study Based on Real World Data
title_short Impact of Cluster B Personality Disorders in Drugs Therapeutic Community Treatment Outcomes: A Study Based on Real World Data
title_sort impact of cluster b personality disorders in drugs therapeutic community treatment outcomes: a study based on real world data
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230360/
https://www.ncbi.nlm.nih.gov/pubmed/34200750
http://dx.doi.org/10.3390/jcm10122572
work_keys_str_mv AT dacostasanchezdaniel impactofclusterbpersonalitydisordersindrugstherapeuticcommunitytreatmentoutcomesastudybasedonrealworlddata
AT diazbatanerocarmen impactofclusterbpersonalitydisordersindrugstherapeuticcommunitytreatmentoutcomesastudybasedonrealworlddata
AT fernandezcalderonfermin impactofclusterbpersonalitydisordersindrugstherapeuticcommunitytreatmentoutcomesastudybasedonrealworlddata
AT lozanooscarm impactofclusterbpersonalitydisordersindrugstherapeuticcommunitytreatmentoutcomesastudybasedonrealworlddata